- Resources
- Mentoring
- Getting Involved
- ATS Reading List
- Depracated
- ARDS
- Asthma
- Bone Marrow Transplantation
- Cardiology Critical Care
- Community-acquired Pneumonia
- COPD
- Cough
- Cystic Fibrosis
- End of Life Care in the ICU
- Endocrine Critical Care
- ENT Critical Care
- Gastroenterology Critical Care
- Hemoptysis
- HIV and Pulmonary Disease
- Interstitial Lung Disease
- Lung Cancer/Solitary Pulmonary Nodule
- Lung Transplantation
- Mycobacterial Diseases
- Nephrology Critical Care
- Neurology Critical Care
- Obstetrics and Critical Care
- Occupational and Environmental Medicine
- Pleural Diseases
- Perioperative Pulmonary Assessment and Management
- Procedures
- Pulmonary Embolism
- Pulmonary Function Testing
- Pulmonary Hypertension
- Sedation / Analgesia / Delirium
- Sepsis / Septic Shock
- Sleep Medicine
- Smoking Cessation
- Transfusion in Critical Care
- Tuberculosis
- Ventilator-associated Pneumonia
- Pulmonary Rehabilitation
- Ventilation and Weaning
- Immunocompromised Host
- Drug Induced Lung Disease
- Nutrition in Critical Illness
- Bronchiectasis (Non-Cystic Fibrosis)
Residents and Medical Students
Nici L, Donner C, Wouters E, et al. American Thoracic Society / European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med 2006;173:1390-1439. A comprehensive statement that presents recent advances in our understanding of how pulmonary rehabilitation can address the multisystemic effects of chronic respiratory disease.
PMID: 16760357
Free Full Text
Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131:4S-42S. An evidence-based guideline statement that provides both critical review of the literature and practical recommendations for pulmonary rehabilitation.
PMID: 17494825
Free Full Text
Ferreira A, Garvey C, Connors GL, et al. Pulmonary Rehabilitation in Interstitial Lung Disease: Benefits and Predictors of Response. Chest 2009;135;442-447. While extensive data exists supporting the benefits of pulmonary rehabilitation in COPD, recent evidence is emerging regarding the benefits to those with ILD. This multicenter observational study of 113 patients with ILD demonstrated that 6-8 weeks of pulmonary rehabilitation provided modest but significant improvements in (Borg) dyspnea score and 6 minute walk distance. The improvement was most pronounced in those with the lowest baseline performance, and gives weight to the argument that pulmonary rehab should be considered in the core management of ILD.
PMID: 18849399
Free Full Text
Last reviewed: February 2015
